Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 06-2020 | 06-2019 | 06-2018 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,387 | -3,446 | -5,144 | -6,700 | -6,162 |
| Depreciation Amortization | 217 | 214 | 167 | 109 | 97 |
| Accounts receivable | 31 | -890 | 38 | -466 | -184 |
| Other Working Capital | -67 | -835 | -518 | 222 | 17 |
| Other Operating Activity | 369 | 1,316 | 408 | 1,123 | 520 |
| Operating Cash Flow | $-2,837 | $-3,641 | $-5,049 | $-5,712 | $-5,712 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 825 | 2,214 | 2,181 |
| PPE Investments | -380 | -273 | -410 | -337 | -543 |
| Other Investing Activity | -30 | -14 | -14 | -18 | -124 |
| Investing Cash Flow | $-410 | $-287 | $401 | $1,859 | $1,514 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 64,693 | 1,005 | 7,385 | 532 | 2 |
| Dividend Paid | -9 | -11 | -11 | -11 | -11 |
| Financing Cash Flow | $64,684 | $994 | $7,374 | $521 | $-9 |
| Beginning Cash Position | 2,573 | 5,507 | 2,781 | 6,113 | 10,320 |
| End Cash Position | 64,010 | 2,573 | 5,507 | 2,781 | 6,113 |
| Net Cash Flow | $61,437 | $-2,934 | $2,726 | $-3,332 | $-4,207 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,837 | -3,641 | -5,049 | -5,712 | -5,712 |
| Capital Expenditure | -381 | -273 | -444 | -337 | -549 |
| Free Cash Flow | -3,218 | -3,914 | -5,493 | -6,049 | -6,261 |